# Page 1
Administrative approval for procurement of medicines required for implementation of STEMI project from the grant received under NPCDCS programme in the approved Action Plan for FY 2019-20 under National Health Mission.
The Government of Maharashtra
the Department of Public Health
Government Resolution No: PRASHAMA-0519/ PR No.333/ HEALTH-7
10th Floor, Gokuldas Tejpal Hospital Complex Building
New Ministry, Mumbai 400001.
The date: September 18, 2019.
Public Health Department Government Resolution No.Prasama-0519/ PR No. 333/ Health-7, dated 16th July, 2019.
2) Letter from Joint Director, Health Services (Non-Communicable Diseases), Mumbai No.
379-1/ STEMI Project/ P.M./ Corrigendum/ 2096-97 dated 31st July, 2019.
Approval of the Commissioner (Health Services) and Mission Director, National Health Mission, Mumbai dated 30th July, 2019.
The Proposal:
Under the approved action plan for the financial year 2019-20 under the National Health Mission, the STEMI project will be implemented in 10 districts of the state from the grant received under the NPCDCS program. In order to purchase the necessary medicines. 16/07/2019 As per the Government decision, an estimated amount of Rs. The administrative approval was given for a purchase proposal of Rs 309.97 lakh. The government was contemplating to take a decision in this regard.
Government's decision:
Under the approved action plan for the financial year 2019-20 under the National Health Mission, the STEMI project will be implemented in a total of 10 districts of the state including Pune, Thane, Amravati, Aurangabad, Nanded, Chandrapur, Wardha, Nagpur, Ratnagiri and Solapur from the grant received under the NPCDCS program. The estimated cost of the drugs is Rs. 309.97 lakh for the above-mentioned proposals. Pursuant to the Governing Decision dated 16/07/2019
# Page 2
Government Resolution Purse No: PRASHAMA-0519/ PR No.333/ HEALTH-7
Administrative approval has been given. However, in this case, at the meeting of STEMI project experts
The types of drugs proposed as per the decision taken on the purchase of drugs and
the Joint Director, Health Services (Non-Communicable Diseases), in accordance with the change in the number of purchases
In the present case, in pursuance of the proposal received on the request made by Mumbai, the following
To grant revised administrative approval subject to the following conditions as mentioned in the prospectus
It's coming
Details of grant-in-aid
----------------------------------------------------------------------------------------------------------------------------------------------------------
| Sr. no | FMR Code          | Name of Head                             | Approved Budget in PIP in 2019-20 (In Lakhs) | Procurement Proposal (In Lakhs) |
| 1      | FMR Code 6.2.19.1 | Drugs & Supplies for District NCD Clinic | 658.00                                       | 309.97                          |
----------------------------------------------------------------------------------------------------------------------------------------------------------
B- Details of the proposed purchase
------------------------------------------------------------------------------------------------------------------------------------------------------------------
| Sr. No               | Name of the drugs   |                                   | Unit Cost Approx. ( Rs. ) | Quantity  |          | Total cost Approx. ( Rs. ) |
| 1                    |                     | Inj.Streptokinase 7.5 lakhs/Vial  | 796.32                    | 8500      | 6768720  |
| 2                    |                     | Inj. Tencetaplase ( TNK TPA) 50mg | 28600                     | 250       | 7150000  |
| 3                    |                     | Inj. Reteplase 10 IU              | 22160                     | 500       | 11080000 |
| Sub Total (A)        | 2,49,98,720         |
| 4                    |                     | Inj. Heparin 5000 IU/ml           | 35.93                     | 56250     | 2021063  |
| 5                    |                     | Tab Aspirin 75mg                  | 0.21                      | 150000    | 31500    |
| 6                    |                     | Tab Clopidrogel 75mg              | 0.61                      | 150000    | 91500    |
| 7                    | Tab Sorbitrate 5 mg | 0.75                              | 75000                     | 56250     |
| 8                    |                     | Inj. Morphine 10 mg               | 25                        | 37500     | 937500   |
| 9                    |                     | Enalpril 5 mg                     | 0.26                      | 168750    | 43875    |
| 10                   |                     | Tab Metaprolol 50                 | 0.578                     | 168750    | 97538    |
| 11                   |                     | Tab Atrovastatin 40               | 17                        | 150000    | 2550000  |
| 12                   |                     | Inj. Xylocard 2%                  | 1                         | 10000     | 10000    |
| 13                   |                     | Inj. Amiodarone 50mg/ml           | 16                        | 10000     | 160000   |
| Sub Total (B)        |                     | 5999226                           |
| Grand Total (A + B ) | 3,09,97,946         |
------------------------------------------------------------------------------------------------------------------------------------------------------------------
Conditions:
1) The requirement/ demand for the said medicinal product should be ascertained.
Thereafter, the tender process will be initiated.
Page 2 of 5
# Page 3
Government Resolution Purse No: PRASHAMA-0519/ PR No.333/ HEALTH-7
2) It should be ensured that the specifications of the said medicinal ingredients are as per the requirement and up to date. The technical specifications of the items to be procured should be as per the specifications agreed by the concerned experts (Technical Committee/ Officials). Also, it should be ensured that the technical specification is not designed in such a way that it will benefit any particular company. The responsibility of sending the requisition as per the technical specifications of the items approved in the PIP will be of the concerned programme head. Only the items included in the proposal should be purchased.
(3) The prescribed procurement procedure should be carried out in accordance with the provisions of the revised rule book of procedures for office procurement to be carried out by government departments published under the Government Decision, Industry, Energy and Labor Department, No. Bhankhas-2014/ PR No. 82/ Part-III/ Industry-4, dated December 1, 2016.
4) The rates of the proposed procurement are estimated at the time of granting administrative approval. Therefore, the lowest prices available on the GeM Portal, other state prices, National Pharmaceutical Pricing Authority (NPPA) should be considered. Further, the minimum rates received in the tender should be taken into account while considering the minimum rates if any in Haffkine Institute and accordingly the rates should be recorded as estimated rates in respect of drugs, pharmaceuticals and equipment to be called for tender and fixed at the end of the procurement process. It should be ensured that the price is less than the market price and not more than the rate at which the supplier has supplied the item to other places.
5) Pre/ post dispatch random sample inspection of the items to be purchased should be done to ensure that only the items with proper and correct specifications are purchased.
6) Storage and distribution of the items to be purchased after supply, supply chain management and inventory management should be done in a proper manner to ensure that these items do not remain unused and are used in a timely manner.
Page 3 of 5
# Page 4
Government Resolution Purse No: PRASHAMA-0519/ PR No.333/ HEALTH-7
7) The expenditure for procurement of drugs& supplies for District NCD Clinic under FMR Code 6.2.19.1 for implementation of STEMI Project under NPCDCS programme in the Action Plan approved by the Central Government for the financial year 2019-20 is Rs. Rs. 658.00 lakh to be met from the sanctioned grant. The procurement should be completed within the stipulated period of administrative approval.
8) Also, it should be ensured that there is no duplication in the purchase of these items.
The Central Vigilance Commission (CVC) guidelines should be strictly followed while carrying out the entire procurement process.
30/ Part- 2/2013/ Regulations, dated 17th April, 2015 in Annexure A No. 4 to the Financial Powers Rules, 1978, Part I, Sub-Section-II, Rule No. 7 in front of No. 6 conditions must be met.
Supply orders should be issued only after the approval of the Purchasing Committee after the completion of the procurement process. In this regard, the Public Health Department, vide Government Resolution No. buy
Action to be taken as per the provisions of the Government Resolution dated 26th July, 2017.
The Commissioner (Health Services) and Mission Director, National Health Mission, Mumbai, Director (Health Services), Directorate of Health Services, Mumbai, Joint Director, Health Services (Procurement Cell), Directorate of Health Services, Mumbai and Programme Head will be fully responsible for ensuring that the procurement is as per the norms and requirements.
Government Resolution, Department of Finance, vide No. 2013/ P.S. 30/13/ Regulations, Part-II, dated 17th April, 2015, in the Financial Powers Rules, 1978, Part-I, Sub-Section-II, No. 4, Rule No. Under Section 7, the administrative department has been given full powers to approve the purchase of implements, spare parts and activity kits.
# Page 5